Bruno Martins

Education

Ph.D., economics, Boston University; M.A. and B.A., economics, Nova School of Business and Economics

Summary of Experience

Dr. Martins is an applied health economist who specializes in real-world evidence (RWE) generation and health economics and outcomes research (HEOR). His experience includes the design and execution of primary data research studies, including cross-sectional and prospective longitudinal surveys, medical chart-review studies, and qualitative research. His experience also encompasses the analysis of both clinical trial data and real-world databases (including health insurance claims and electronic medical records), as well as indirect treatment comparisons. Dr. Martins has contributed to studies across a wide range of disease areas, including dermatology, immunology, gastroenterology, neurology, oncology, and cardiovascular diseases. His work has been published in numerous peer-reviewed journals and presented at clinical and economic research conferences.

• Prurigo Nodularis PaTient-Reported BurdEn of SicKness (PN TREK): A Cross-Sectional Survey of Patient-Reported Burden of Disease in Patients with PN from the US

  Advances in Therapy, 2025
  2025

  Kwatra SG, Yang M, Martins B, Zion A, Liu J, Zahn J, Ozarslan B, Bahloul D, Payan M, Thomas RB

  HEOR, Epidemiology & Market Access
• Real-world treatment patterns in patients with chronic rhinosinusitis with nasal polyps who initiated dupilumab: A US claims analysis

  Journal of Allergy and Clinical Immunology: Global, 2025
  2025

  Pinto JM, Fillbrunn M, Martins B, Yang M, Chen C, Nash S, Corbett M, Gandhi A, Wang Z

  HEOR, Epidemiology & Market Access
• Structured Literature Review to Identify Human Papillomavirus's Natural History Parameters for Dynamic Population Models of Vaccine Impacts

  Infectious Diseases and Therapy, 2024
  2024

  Diakite I, Martins B, Owusu-Edusei K, Palmer C, Patterson-Lomba O, Gomez-Lievano A, Zion A, Simpson R, Daniels V, Elbasha E

  HEOR, Epidemiology & Market Access
• Long-Term Effectiveness of Dupilumab in Patients with Atopic Dermatitis: Results up to 3 Years from the RELIEVE-AD Study

  Dermatology and Therapy, August 8, 2023
  2023

  Kimball AB, Delevry D, Yang M, Chuang C, Wang Z, Bégo-Le-Bagousse G, Martins B, Wu EQ, Shumel B, Wang J, Sierka D, Chao J, Strober B

  HEOR, Epidemiology & Market Access, Marketing, Consumer Behavior & Surveys

• December 7, 2023

  Analysis Group Coauthors Explore Novel Method for Assessing Real-World Data on Longitudinal Patient-Reported Outcomes

  HEOR, Epidemiology & Market Access, Marketing, Consumer Behavior & Surveys